Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adagene

1.77
-0.1986-10.08%
Post-market: 1.77-0.0014-0.08%19:57 EDT
Volume:59.20K
Turnover:110.94K
Market Cap:78.42M
PE:-2.44
High:1.96
Open:1.93
Low:1.75
Close:1.97
Loading ...
OverviewCompanyAnalysisNewsFilings

Company Profile

Company Name:
Adagene
Exchange:
NASDAQ
Establishment Date:
2011
Employees:
174
Office Location:
Building C14,4th Floor,No. 218, Xinghu Street,Suzhou Industrial Park,Suzhou,Jiangsu Province,China
Website:
- -
Zip Code:
215123
Phone:
86 512 8777 3632
Fax:
- -
Introduction:
Adagene Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Their platform is designed to generate therapeutic antibody candidates with unique functional epitopes and species cross-reactivity. These features enable their novel drug discovery strategy to advance from lead identification through vigorous preclinical modeling to biomarker-guided mono- and combination immunotherapy development in clinical settings. They have pioneered a dynamic interface design to harness the conformational diversity of antibodies, which enlarges epitope sampling of a given drug target for differentiated therapeutic antibody development. Their platform is designed to enable the rapid development of precision immunotherapy candidates, through the identification of predictive biomarkers for patient stratification and preselection.

Directors

Name
Position
Peter Luo
Co-Founder, Chief Executive Officer, President of R&D and Chairman of the Board
Andy Cheung
Independent Director
Cuong Do
Independent Director
Li Zhu
Independent Director
Man Kin Tam
Chief Financial Officer and Director
Mervyn Turner
Independent Director
Ulf Grawunder
Independent Director
Yumeng Wang
Director

Shareholders

Name
Position
Peter Luo
Co-Founder, Chief Executive Officer, President of R&D and Chairman of the Board
Guizhong Liu
Senior Vice President of Early Drug Discovery
Man Kin Tam
Chief Financial Officer and Director
Xiaohong She
Senior Vice President, Head of Clinical Operations
Yan Li
Senior Vice President, Bioinformatics and Information Technology
Alexander Goergen
Vice President, Head of Business Development
Ami Knoefler
Vice President of Investor Relations and Corporate Communications
Chunfang Gu
Senior Director of Finance
Dana Hu Lowe
Vice President of Global Product Team Leadership
JC Xu
Chief Scientific Officer
Jiping Zha
Executive Vice President of Clinical Development
Ling Zhou
Executive Director of Human Resources
Qinghai Zhao
Chief Manufacturing Officer
Songmao Zheng
Vice President, Head of Clinical and Quantitative Pharmacology
Wenlin Zeng
Vice President of Early Stage CMC